Prevalence of the most frequent BRCA1 mutations in Polish population

被引:38
|
作者
Brozek, Izabela [1 ]
Cybulska, Celina [1 ]
Ratajska, Magdalena [1 ]
Piatkowska, Magdalena [2 ,3 ]
Kluska, Anna [2 ,3 ]
Balabas, Aneta [2 ,3 ]
Dabrowska, Michalina [2 ,3 ]
Nowakowska, Dorota [2 ,3 ]
Niwinska, Anna [2 ,3 ]
Pamula-Pilat, Jolanta [4 ,5 ]
Tecza, Karolina [4 ,5 ]
Pekala, Wioletta [4 ,5 ]
Rembowska, Jolanta [6 ]
Nowicka, Karina [6 ]
Mosor, Maria [6 ]
Januszkiewicz-Lewandowska, Danuta [6 ]
Rachtan, Jadwiga [7 ]
Grzybowska, Ewa [4 ,5 ]
Nowak, Jerzy [6 ]
Steffen, Jan [2 ,3 ]
Limon, Janusz [1 ]
机构
[1] Med Univ Gdansk, Dept Biol & Genet, PL-80211 Gdansk, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Immunol, Warsaw, Poland
[3] Inst Oncol, Warsaw, Poland
[4] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol Biol, Gliwice, Poland
[5] Inst Oncol, Gliwice, Poland
[6] Polish Acad Sci, Inst Human Genet, Dept Mol Pathol, PL-60479 Poznan, Poland
[7] Maria Sklodowska Curie Mem Inst Oncol, Epidemiol Unit, Ctr Oncol, Krakow, Poland
关键词
BRCA1; mutations; BRCA1 in Poland; Hereditary breast cancer; OVARIAN-CANCER FAMILIES; BREAST-CANCER; FOUNDER MUTATIONS; BREAST/OVARIAN CANCER; CARRIERS; RISK; GENE; HEREDITARY; WOMEN; 5382INSC;
D O I
10.1007/s13353-011-0040-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The purpose of our study was to establish the frequency and distribution of the four most common BRCA1 mutations in Polish general population and in a series of breast cancer patients. Analysis of the population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3819del5 (c.3700_3704del5) mutations of the BRCA1 gene were performed on a group of respectively 16,849, 13,462, 12,485 and 3923 anonymous samples collected at birth in seven Polish provinces. The patient group consisted of 1845 consecutive female breast cancer cases. The most frequent BRCA1 mutation in the general population was 5382insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respectively 11 of 13,462 (0.08%)and four of 3923 (0.1%) samples. The population prevalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer cases were, respectively, 1.9% (35/1845) and 1.2% (18/1486). Comparing these data with the population frequency, we calculated the relative risk of breast cancer for 5382insC mutation at OR = 17 and for 300T >G mutation at OR = 26. Our results, based on large population studies, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general population. Carriage of one of these mutations is connected with a very high relative risk of breast cancer.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 50 条
  • [1] Prevalence of the most frequent BRCA1 mutations in Polish population
    Izabela Brozek
    Celina Cybulska
    Magdalena Ratajska
    Magdalena Piatkowska
    Anna Kluska
    Aneta Balabas
    Michalina Dabrowska
    Dorota Nowakowska
    Anna Niwinska
    Jolanta Pamula-Pilat
    Karolina Tecza
    Wioletta Pekala
    Jolanta Rembowska
    Karina Nowicka
    Maria Mosor
    Danuta Januszkiewicz-Lewandowska
    Jadwiga Rachtan
    Ewa Grzybowska
    Jerzy Nowak
    Jan Steffen
    Janusz Limon
    Journal of Applied Genetics, 2011, 52 : 325 - 330
  • [2] BRCA1 and BRCA2 mutations and female fertility
    Smith, Ken R.
    Hanson, Heidi A.
    Hollingshaus, Michael S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (03) : 207 - 213
  • [3] Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era
    Zidekova, D.
    Waczulikova, I
    Dolesova, L.
    Vavrova, L.
    Hamidova, O.
    Rehulova, R. Lohajova
    Konecny, M.
    NEOPLASMA, 2018, 65 (02) : 309 - 315
  • [4] A high frequent BRCA1 founder mutation identified in the Greenlandic population
    Harboe, Theresa Larriba
    Eiberg, Hans
    Kern, Peder
    Ejlertsen, Bent
    Nedergaard, Lotte
    Timmermans-Wielenga, Vera
    Nielsen, Inge-Merete
    Bisgaard, Marie Luise
    FAMILIAL CANCER, 2009, 8 (04) : 413 - 419
  • [5] BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study
    Kowalik, Artur
    Siolek, Monika
    Kopczynski, Janusz
    Krawiec, Kamila
    Kalisz, Joanna
    Zieba, Sebastian
    Kozak-Klonowska, Beata
    Wypiorkiewicz, Elzbieta
    Furmanczyk, Jowita
    Nowak-Ozimek, Ewelina
    Chlopek, Matgorzata
    Macek, Pawel
    Smok-Kalwat, Jolanta
    Gozdz, Stanislaw
    PLOS ONE, 2018, 13 (07):
  • [6] Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellin, Colombia
    Londono Hernandez, Julian Esteban
    Llacuachaqui, Marcia
    Vasquez Palacio, Gonzalo
    David Figueroa, Juan
    Madrid, Jorge
    Lema, Mauricio
    Royer, Robert
    Li, Song
    Larson, Garrett
    Weitzel, Jeffrey N.
    Narod, Steven A.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2014, 12
  • [7] A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
    Donenberg, Talia
    Lunn, John
    Curling, DuVaughn
    Turnquest, Theodore
    Krill-Jackson, Elisa
    Royer, Robert
    Narod, Steven A.
    Hurley, Judith
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 591 - 596
  • [8] Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: The public health perspective
    Narod, Steven A.
    SALUD PUBLICA DE MEXICO, 2009, 51 : S191 - S196
  • [9] Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico
    Dutil, Julie
    Colon-Colon, Jose L.
    Matta, Jaime L.
    Sutphen, Rebecca
    Echenique, Miguel
    CANCER GENETICS, 2012, 205 (05) : 242 - 248
  • [10] Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
    Abugattas, J.
    Llacuachaqui, M.
    Allende, Y. Sullcahuaman
    Velasquez, A. Arias
    Velarde, R.
    Cotrina, J.
    Garces, M.
    Leon, M.
    Calderon, G.
    de la Cruz, M.
    Mora, P.
    Royer, R.
    Herzog, J.
    Weitzel, J. N.
    Narod, S. A.
    CLINICAL GENETICS, 2015, 88 (04) : 371 - 375